Since this herb is supposed to increase blood vessel dilation, does anyone know offhand if it has been tested in RSD patients?

LogicWoman

Hi logic woman,
Welcome. I really don't know. I did a search and came up with nothing. Maybe someone else can find something. Interesting question, though. I've been dx'd with RSD for 20 years and that is the first I have seen that question. I have taken it before, but with so many other treatments going on at the same time, I couldn't tell you if there was any effects. I have been using Hyperbaric Oxygen Therapy, to help. I hope someone else can give you a better answer. Great to see you here. Hugs di

It's a big help for me but one pschiatrist told me there were no studies on it. I haven't investigated.

Spelling is ginko biloba. Found one article related to peripheral neuropathy:

The effect of Ginkgo extract EGb761 in cisplatin-induced peripheral neuropathy in mice.

Oztürk G, Anlar O, Erdo?an E, Kösem M, Ozbek H, Türker A.
Department of Physiology, Neuroscience Research Unit, Medical School, Yüzüncü Yil University, Van, Turkey. drgurkan@yyu.edu.tr

Neuroprotective effect of Ginkgo biloba extract EGb761 in cisplatin (cis-diamminedi-chloroplatinum, or CDDP)-induced peripheral neuropathy was investigated. Swiss albino mice were treated with CDDP, 2 mg/kg ip twice a week for nine times. One group of the animals also received EGb761 in the drinking water at an estimated dosage of 100 mg/kg per day. Two other groups received vehicle (control) or EGb761 only. Development of neuropathy was evaluated with changes in sensory nerve conduction velocity (NCV). Following the treatments, dorsal root ganglia (DRGs) were microscopically examined and some were cultured for 3 days. EGb761 proved effective in preventing the reduction in NCV (P < 0.0001) caused by CDDP. CDDP caused a decrease in the number of migrating cells (P < 0.01) and in the length of outgrowing axons (P < 0.01) while EGb761 treatment prevented the latter. CDDP led to smaller nuclear and somatic sizes in neurons (P < 0.01), while with EGb761 co-administration, both were close to control values. Animals having EGb761 only had similar results with controls. In conclusion, EGb761 was found to be effective in preventing some functional and morphological deteriorations in CDDP-induced peripheral neuropathy.

Thanks for taking the time to research that. Interesting!!!